Mercator Medical Valuation
| MRC Stock | 47.45 0.45 0.96% |
At this time, the firm appears to be overvalued. Mercator Medical secures a last-minute Real Value of USD42.8 per share. The latest price of the firm is USD47.45. Our model forecasts the value of Mercator Medical from analyzing the firm fundamentals such as Current Valuation of 35.23 M, return on equity of 0.0179, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Mercator Medical's price fluctuation is very steady at this time. Calculation of the real value of Mercator Medical is based on 3 months time horizon. Increasing Mercator Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mercator stock is determined by what a typical buyer is willing to pay for full or partial control of Mercator Medical SA. Since Mercator Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mercator Stock. However, Mercator Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 47.45 | Real 42.8 | Hype 47.45 | Naive 46.58 |
The intrinsic value of Mercator Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mercator Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mercator Medical SA helps investors to forecast how Mercator stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mercator Medical more accurately as focusing exclusively on Mercator Medical's fundamentals will not take into account other important factors: Mercator Medical Total Value Analysis
Mercator Medical SA is now projected to have takeover price of 35.23 M with market capitalization of 438.69 M, debt of 0, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Mercator Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.23 M | 438.69 M | 0 |
Mercator Medical Investor Information
About 64.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.4. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mercator Medical last dividend was issued on the 18th of June 2020. Based on the analysis of Mercator Medical's profitability, liquidity, and operating efficiency, Mercator Medical SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Mercator Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Mercator connotes not a very effective usage of assets in November.Mercator Medical Ownership Allocation
The market capitalization of Mercator Medical SA is USD438.69 Million. Mercator Medical SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.49 % of Mercator Medical SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Mercator Medical Profitability Analysis
The company reported the revenue of 1.73 B. Net Income was 446.87 M with profit before overhead, payroll, taxes, and interest of 725.31 M.About Mercator Medical Valuation
The stock valuation mechanism determines Mercator Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Mercator Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mercator Medical. We calculate exposure to Mercator Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mercator Medical's related companies.8 Steps to conduct Mercator Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Mercator Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Mercator Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Mercator Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Mercator Medical's revenue streams: Identify Mercator Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Mercator Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Mercator Medical's growth potential: Evaluate Mercator Medical's management, business model, and growth potential.
- Determine Mercator Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Mercator Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Mercator Stock Analysis
When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.